James G. Wilson

Molecular Biology · 2010–2021

A researcher in the Science corpus: 23 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 270 citations into it
• Physiology — 21 citations into it

Whom James G. Wilson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Steve Horvath

Papers from James G. Wilson's perspective

Ordered by how strongly the researchers James G. Wilson trusts endorse each paper. Same corpus, a different order for every researcher.

1. DNA methylation arrays as surrogate measures of cell mixture distribution (BMC Bioinformatics)
2. Common SNPs explain a large proportion of heritability for human height (Nature Genetics)
3. Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age? (The journals of gerontology. Series A, Biological sciences and medical sciences)
4. Quantification of biological aging in young adults (Proceedings of the National Academy of Sciences of the United States of America)
5. GCTA: a tool for genome-wide complex trait analysis. (American Journal of Human Genetics)
6. DNA methylation age of human tissues and cell types (Genome Biology)
7. Epigenetic Signatures of Cigarette Smoking (Circulation: Cardiovascular Genetics)
8. DNA methylation age of blood predicts all-cause mortality in later life (Genome Biology)
9. Overview and Findings from the Rush Memory and Aging Project (Current Alzheimer Research)
10. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. (American Journal of Human Genetics)

Their papers

• Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies (2018) — 681 citations
• An epigenetic biomarker of aging for lifespan and healthspan (2018) — 3,003 citations
• Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program (2019) — 1,941 citations
• The genetic architecture of type 2 diabetes (2016) — 1,066 citations
• DNA methylation GrimAge strongly predicts lifespan and healthspan (2019) — 2,021 citations
• HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (2015) — 671 citations
• Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals (2019) — 162 citations
• The power of genetic diversity in genome-wide association studies of lipids (2021) — 765 citations
• A structural variation reference for medical and population genetics (2020) — 876 citations
• Evaluating drug targets through human loss-of-function genetic variation (2019) — 168 citations
• A catalog of genetic loci associated with kidney function from analyses of a million individuals (2019) — 744 citations
• Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes (2018) — 1,405 citations
• Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease (2018) — 80 citations
• Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes (2017) — 401 citations
• Diagnostic Yield of Sequencing Familial Hypercholesterolemia Genes in Severe Hypercholesterolemia (2016) — 842 citations
• Age-related clonal hematopoiesis associated with adverse outcomes. (2014) — 4,169 citations
• Loss-of-Function Mutations in APOC 3 , Triglycerides , and Coronary Disease (2014) — 861 citations
• Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data (2014) — 637 citations
• Mendelian randomization of blood lipids for coronary heart disease (2014) — 726 citations
• Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico (2013) — 472 citations